Literature DB >> 9302823

[Histopathologic findings for the research of acid-fast bacilli in erythema nodosum].

M C Pires1, M de J Calux, N Y Valente.   

Abstract

It was possible to prove, by means of retrospective histopathological studies of 51 glass slides of common erythema nodosum (EN) and 39 glass slides of erythema nodosum leprosum (ENL), that the histopathological features of the two groups differed in several ways. It was found that the most prominent divergent findings between these two diseases was the presence of a lepromatous granulomatous infiltrate in the ENL; the predominant location of the inflammatory infiltrate was derma-hypodermal in ENL and hypodermal in common EN; there was a preferential septa attack in common EN and lobular in ENL; foreign giant cells occurred only in common EN; the lymphocyte cell infiltration in common EN and of neutrophils in ENL and the presence of inflammatory infiltrate around nerves in ENL. Our study has proved that the search for M. leprae does not have to be made in all cases of EN as there are histological differences in the routine histopathological exam between common EN and ENL that can alert to the real need for this procedure. This search must be performed when during the routine histopathological exam of sections stained by hematoxilin-eosin the ENL histopathological characteristics delineated herein are observed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9302823     DOI: 10.1590/s0034-89101996000600007

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  2 in total

1.  Ocular erythema nodosum leprosum: An immunohistochemical study.

Authors:  S R Rathinam; Jignesh G Parikh; Narsing A Rao
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

2.  Histopathological study of ocular erythema nodosum leprosum and post-therapeutic scleral perforation: a case report.

Authors:  S R Rathinam; Hadi M Khazaei; C K Job
Journal:  Indian J Ophthalmol       Date:  2008 Sep-Oct       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.